Table 3.
Practical diagnostic considerations of RT-PCR test and Serological immunoassay.
| RT-PCR test | Antibody test | |
|---|---|---|
| Merit | Highly specific | Easy to use serological sample |
| Limitation | Sensitivity can suffer due to sampling errors or insufficient viral load (false negatives). Inactive virus and viral fragments could also test positive (false positives). | Generally not as accurate as RT-PCR test, with false positives and false negatives. False positives in a low prevalence population can give an exaggeration of exposure and immunity. (e.g., a specificity of 99% in a population of 1% prevalence can lead to ~50% of positive results being false.) |
| Remedy | Testing twice sequentially to improve sensitivity (e.g., a single test sensitivity of 70% would result in a 2-test sensitivity of 91%) and/or combination with chest CT scan and clinical factors | Assay validation with sufficient positive and negative sample cohorts; generally cannot be used to diagnose newly infected patients, but can be used as a screening test (Optimizing antibody test sensitivity for rule-out, optimizing specificity for rule-in) |
| Primary utility | Standard of care diagnosis of newly infected and/or active Covid-19 patients. | Screening test for stratifying newly infected patients, remotely infected patients, and asymptomatic patients; surveillance assay for seroprevalence, immunity and vaccination efficacy. |